← Back to Search

Behavioral Intervention

Contingency Management for Schizophrenia

N/A
Waitlist Available
Led By Martin Paulus, MD
Research Sponsored by Laureate Institute for Brain Research, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of Schizophrenia Spectrum, Bipolar, or Related Disorders
Age 18-65 years old
Must not have
Cognitive impairment that would interfere with participation in the study
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to see if giving money incentives to mentally ill homeless individuals with schizophrenia or bipolar disorder can help reduce their disruptive behaviors in the community. Up to 15 participants will meet weekly with their case

Who is the study for?
This trial is for unhoused individuals in Tulsa with schizophrenia or bipolar disorder who also have anosognosia, meaning they're not aware of their mental health condition. Participants should display problematic behaviors and will work with a case manager weekly.
What is being tested?
The study tests if giving money can help reduce disruptive behaviors in the participants. They get $10 for discussing life goals and an extra $20 for trouble-free weeks, which increases by $1 each successful week.
What are the potential side effects?
Since this trial involves monetary incentives rather than medication, traditional side effects are not expected. However, there may be psychological impacts from receiving or failing to receive the incentives.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a condition within the schizophrenia spectrum, bipolar disorder, or a related disorder.
Select...
I am between 18 and 65 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My thinking or memory problems do not prevent me from participating in studies.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Reduction in disruptive behaviors

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Contingency ManagementExperimental Treatment1 Intervention
Meet weekly for 30 minutes with their case manager to discuss progress on life goals ($10) and for having seven days with no disruptive behaviors (or "trouble-free days") per week at each visit, they will receive an additional baseline payment of $20, increasing with continued success in subsequent weeks by $1 per week.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Contingency Management
2014
Completed Phase 4
~3440

Find a Location

Who is running the clinical trial?

Laureate Institute for Brain Research, Inc.Lead Sponsor
52 Previous Clinical Trials
5,425 Total Patients Enrolled
2 Trials studying Bipolar Disorder
119 Patients Enrolled for Bipolar Disorder
Tulsa Day CenterUNKNOWN
Martin Paulus, MDPrincipal InvestigatorLaureate Institute for Brain Research
1 Previous Clinical Trials
75 Total Patients Enrolled
~6 spots leftby Dec 2025